Compounds > azacitidine

azacitidine and Lymphoma, T-Cell, Cutaneous

azacitidine has been researched along with Lymphoma, T-Cell, Cutaneous in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Apel, A; Arnason, J; Avigan, D; Bhargava, P; Clark, RA; Cole, L; Jain, S; Kufe, D; Kupper, TS; Leaf, RK; Nahas, M; Pyzer, A; Rosenblatt, J; Stroopinsky, D; Washington, A1
Cheng, PF; Dummer, R; Fujii, K; Levesque, MP; Rozati, S; Widmer, DS1
Colizzi, F; Dolcetti, R; Fratta, E; Montico, B; Rizzo, A; Sigalotti, L1
Wood, GS; Wu, J1
El-Salem, M; Gimotty, P; Marzec, M; Nagasawa, T; Odum, N; Raghunath, PN; Rook, AH; Szallasi, A; Vonderheid, EC; Wasik, MA; Wong, HY; Zhang, Q1
Odum, N; Raghunath, PN; Vonderheid, E; Wasik, MA; Zhang, Q1

Reviews

1 review(s) available for azacitidine and Lymphoma, T-Cell, Cutaneous

ArticleYear
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.
    Oncotarget, 2016, Aug-30, Volume: 7, Issue:35

    Topics: Acetylation; Antineoplastic Agents; Azacitidine; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Hematologic Neoplasms; Histones; Humans; Lymphoma, T-Cell, Cutaneous; Male; Myelodysplastic Syndromes; Protein Domains

2016

Other Studies

5 other study(ies) available for azacitidine and Lymphoma, T-Cell, Cutaneous

ArticleYear
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma.
    Molecular cancer therapeutics, 2017, Volume: 16, Issue:10

    Topics: Animals; Apoptosis; Azacitidine; Cell Line, Tumor; Decitabine; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, T-Cell, Cutaneous; Mice; Mucin-1; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Xenograft Model Antitumor Assays

2017
Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Apr-15, Volume: 22, Issue:8

    Topics: Acetylation; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Cluster Analysis; CpG Islands; Depsipeptides; DNA Methylation; Dose-Response Relationship, Drug; Drug Synergism; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Lymphoma, T-Cell, Cutaneous; Promoter Regions, Genetic; Protein Binding; Sezary Syndrome

2016
Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma.
    Archives of dermatology, 2011, Volume: 147, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; fas Receptor; Female; Humans; Interferon Type I; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Methotrexate; NF-kappa B; Promoter Regions, Genetic; Recombinant Proteins; Skin Neoplasms; Up-Regulation

2011
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
    Leukemia research, 2006, Volume: 30, Issue:3

    Topics: Adult; Anaplastic Lymphoma Kinase; Azacitidine; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p15; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Gene Silencing; Humans; Lymphoma, T-Cell, Cutaneous; Promoter Regions, Genetic; Protein Biosynthesis; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Skin Neoplasms; Time Factors; Tumor Suppressor Protein p14ARF

2006
Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
    The American journal of pathology, 2000, Volume: 157, Issue:4

    Topics: Azacitidine; Base Sequence; Decitabine; DNA Methylation; DNA Modification Methylases; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinase 3; Lymphoma; Lymphoma, T-Cell, Cutaneous; Phosphorylation; Promoter Regions, Genetic; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured

2000